CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Grant or award Chief Development Officer acquired 15,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- S-3MEF Other S-3MEF
- 424B5 Offering Prospectus
- 4 Open-market buy Director bought 9,500 shares at $9.82 ($93,261)
- 4 Open-market sale VP, Finance and Administration sold 21,551 shares at $9.25 ($199,347)
- 4 Open-market buy Director bought 30,000 shares at $5.16 ($154,800)
- 4 Open-market buy Director bought 8,000 shares at $5.21 ($41,712)
- 4 Open-market buy Director bought 47,965 shares at $5.22 ($250,329)
- 8-K Event Material agreement · New debt or obligation · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes VP, Finance and Administration gave up 7,616 shares (to pay taxes)
Page 22 of 33 · 652 filings